Recent studies have shown that the use of statins and/or angiotensin-converting enzyme (ACE) inhibitors prior to admission is associated with decreased mortality in patients hospitalized with pneumonia [8]–[10]. Here, ACE is linked to susceptibility to pneumonia measurement.